Case Report
Published on 08 May 2026
Response to crizotinib treatment for ROS1 p.H1999N mutation and secondary EGFR p.V774M mutation after drug resistance: a Case Report
in Pharmacology of Anti-Cancer Drugs
- 263 views
Case Report
Published on 08 May 2026
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 08 May 2026
in Aging and Public Health
Review
Published on 08 May 2026
in Rheumatology
Study Protocol
Published on 08 May 2026
in Neonatology
Review
Published on 08 May 2026
in Head and Neck Cancer
Original Research
Published on 08 May 2026
in Environmental Toxicology
Review
Published on 08 May 2026
in Virology
Original Research
Published on 08 May 2026
in Psychopathology
Hypothesis and Theory
Published on 08 May 2026
in Diabetes Self-Management
Original Research
Published on 08 May 2026
in Microbial Physiology and Metabolism
Case Report
Published on 08 May 2026
in Brain Health and Clinical Neuroscience
Original Research
Published on 08 May 2026
in Special Educational Needs
Original Research
Published on 08 May 2026
in Radiation and Health
Case Report
Published on 08 May 2026
in Pulmonary Medicine
Original Research
Published on 08 May 2026
in Family Medicine and Primary Care
Original Research
Published on 08 May 2026
in Antimicrobials, Resistance and Chemotherapy